Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy

被引:0
作者
Stella, Claudia [1 ]
Berardi, Cecilia [1 ]
Chiarito, Annalisa [1 ]
Gennenzi, Veronica [2 ]
Postorino, Stefania [2 ]
Settanni, Donatella [2 ]
Cesarano, Melania [2 ]
Xhemalaj, Rikardo [1 ]
Tanzarella, Eloisa Sofia [2 ]
Cutuli, Salvatore Lucio [2 ]
Grieco, Domenico Luca [2 ]
Conti, Giorgio [1 ,2 ]
Antonelli, Massimo [1 ,2 ]
De Pascale, Gennaro [1 ,2 ]
机构
[1] Univ Cattolica Sacro Cuore, Dipartimento Sci Biotecnol Base Clin Intensivol &, Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Emergenza Anestesiol & Rianimaz, Rome, Italy
来源
JOURNAL OF ANESTHESIA ANALGESIA AND CRITICAL CARE | 2023年 / 3卷 / 01期
关键词
COVID-19; Vaccination; Mortality; Intensive care unit; CRITICALLY-ILL PATIENTS; SARS-COV-2;
D O I
10.1186/s44158-023-00130-6
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background COVID-19 vaccination has been proved to be effective in preventing hospitalization and illness progression, even though data on mortality of vaccinated patients in the intensive care unit (ICU) are conflicting. The aim of this study was to investigate the characteristics of vaccinated patients admitted to ICU according to their immunization cycle and to outline the risk factors for 28-day mortality. This observational study included adult patients admitted to ICU for acute respiratory failure (ARF) due to SARS-CoV-2 and who had received at least one dose of vaccine. Results Fully vaccination was defined as a complete primary cycle from < 120 days or a booster dose from > 14 days. All the other patients were named partially vaccinated. One-hundred sixty patients (91 fully and 69 partially vaccinated) resulted eligible, showing a 28-day mortality rate of 51.9%. Compared to partially vaccinated, fully vaccinated were younger (69 [60-77.5] vs. 74 [66-79] years, p 0.029), more frequently immunocompromised (39.56% vs. 14.39%, p 0.003), and affected by at least one comorbidity (90.11% vs 78.26%, p 0.045), mainly chronic kidney disease (CKD) (36.26% vs 20.29%, p 0.035). At multivariable analysis, independent predictors of 28-day mortality were as follows: older age [OR 1.05 (CI 95% 1.01-1.08), p 0.005], history of chronic obstructive pulmonary disease (COPD) [OR 3.05 (CI 95% 1.28-7.30), p 0.012], immunosuppression [OR 3.70 (CI 95% 1.63-8.40), p 0.002], and admission respiratory and hemodynamic status [PaO2/FiO2 and septic shock: OR 0.99 (CI 95% 0.98-0.99), p 0.009 and 2.74 (CI 95% 1.16-6.48), p 0.022, respectively]. Conclusions Despite a full vaccination cycle, severe COVID-19 may occur in patients with relevant comorbidities, especially immunosuppression and CKD. Regardless the immunization status, predisposing conditions (i.e., older age, COPD, and immunosuppression) and a severe clinical presentation were predictors of 28-day mortality.
引用
收藏
页数:9
相关论文
共 49 条
[1]   Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants [J].
Accorsi, Emma K. ;
Britton, Amadea ;
Fleming-Dutra, Katherine E. ;
Smith, Zachary R. ;
Shang, Nong ;
Derado, Gordana ;
Miller, Joseph ;
Schrag, Stephanie J. ;
Verani, Jennifer R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07) :639-651
[2]   The impact of age on intensive care [J].
Akinosoglou, Karolina ;
Schinas, Georgios ;
Almyroudi, Maria Panagiota ;
Gogos, Charalambos ;
Dimopoulos, George .
AGEING RESEARCH REVIEWS, 2023, 84
[3]   Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review [J].
Al Hajji, Youssra ;
Taylor, Harriet ;
Starkey, Thomas ;
Lee, Lennard Y. W. ;
Tilby, Michael .
BRITISH JOURNAL OF CANCER, 2022, 127 (10) :1827-1836
[4]   Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines [J].
Andrews, Nick ;
Tessier, Elise ;
Stowe, Julia ;
Gower, Charlotte ;
Kirsebom, Freja ;
Simmons, Ruth ;
Gallagher, Eileen ;
Thelwall, Simon ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin ;
Hopkins, Susan ;
Chand, Meera ;
Ladhani, Shamez N. ;
Ramsay, Mary ;
Bernal, Jamie Lopez .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04) :340-350
[5]   COVID-19 in the Critically III Patient [J].
Bell, Taison D. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2022, 36 (02) :365-377
[6]   Coronavirus Disease-2019 in the Immunocompromised Host [J].
Bertini Jr, Christopher D. ;
Khawaja, Fareed ;
Sheshadri, Ajay .
CLINICS IN CHEST MEDICINE, 2023, 44 (02) :395-406
[7]   Characteristics of unvaccinated and vaccinated critically ill COVID-19 patients in calabria region (Italy): A retrospective study [J].
Bruni, Andrea ;
Longhini, Federico ;
Macheda, Sebastiano ;
Biamonte, Eugenio ;
Pasqua, Pino ;
Neri, Giuseppe ;
Guzzo, Maria Laura ;
Garofalo, Eugenio .
FRONTIERS IN MEDICINE, 2022, 9
[8]  
Centers for Disease Control Prevention, 2023, About us
[9]   COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection [J].
Chi, Wei-Yu ;
Li, Yen-Der ;
Huang, Hsin-Che ;
Chan, Timothy En Haw ;
Chow, Sih-Yao ;
Su, Jun-Han ;
Ferrall, Louise ;
Hung, Chien-Fu ;
Wu, T-C .
JOURNAL OF BIOMEDICAL SCIENCE, 2022, 29 (01)
[10]   The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain) [J].
Chico-Sanchez, Pablo ;
Gras-Valenti, Paula ;
Algado-Selles, Natividad ;
Jimenez-Sepulveda, Natali ;
Vanaclocha, Hermelinda ;
Peiro, Salvador ;
Burgos, Javier S. ;
Berenguer, Ana ;
Navarro, David ;
Sanchez-Paya, Jose .
PREVENTIVE MEDICINE, 2022, 163